Evaluating antimicrobial duration for Gram‐negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation.

MLA

Ranganath, Nischal, et al. “Evaluating Antimicrobial Duration for Gram‐negative Bacteremia in Patients with Neutropenia Due to Hematologic Malignancy or Hematopoietic Stem Cell Transplantation.” Transplant Infectious Disease, vol. 25, no. 5, Oct. 2023, pp. 1–9. EBSCOhost, https://doi.org/10.1111/tid.14085.

APA

Ranganath, N., Yetmar, Z. A., McCandless, A. R., Rivera, C. G., Lahr, B. D., Tande, A. J., & Shah, A. S. (2023). Evaluating antimicrobial duration for Gram‐negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation. Transplant Infectious Disease, 25(5), 1–9. https://doi.org/10.1111/tid.14085

Chicago

Ranganath, Nischal, Zachary A. Yetmar, Audrey R. McCandless, Christina G. Rivera, Brian D. Lahr, Aaron J. Tande, and Aditya S. Shah. 2023. “Evaluating Antimicrobial Duration for Gram‐negative Bacteremia in Patients with Neutropenia Due to Hematologic Malignancy or Hematopoietic Stem Cell Transplantation.” Transplant Infectious Disease 25 (5): 1–9. doi:10.1111/tid.14085.